文献速递胸部肿瘤支持与姑息治疗

更新版肺癌生活质量模块QLQ-LC29的心理测量学特性:国际观察性现场研究

Psychometric properties of the updated EORTC module for assessing quality of life in patients with lung cancer (QLQ-LC29): an international, observational field study.
PubMed 文献 · Lancet Oncol · 2020-03-23

该国际观察性研究在12国19家医院纳入523例肺癌患者,评估更新版EORTC QLQ-LC29量表的量表结构与心理测量学特性。验证性因子分析得出5个多条目量表及15个单症状条目,内部一致性、重测信度、敏感性和反应性均获支持,提示该模块可用于国际临床研究。

要点

  • QLQ-LC29含5个多条目量表和15个单症状/副作用条目,结构经验证。
  • 部分量表对体能状态组间差异敏感,并对时间变化有反应性。

核心结论

  • QLQ-LC29的心理测量学特性得到确定,已可用于国际临床研究。

研究设计与样本

  • 国际观察性现场研究,在12个国家19家医院纳入523例确诊肺癌患者。
  • 患者填写EORTC QLQ-C30加QLQ-LC29纸质版,其中半数患者在2–4周后重测。
  • 采用验证性因子分析评估量表结构,Cronbachα和组内相关系数评估信度,t检验和方差分析评估敏感性与反应性。

临床怎么用

  • 可将QLQ-LC29用于国际临床研究中评估肺癌患者的生活质量。
  • 该模块涵盖咳嗽、气短、疾病进展恐惧、头发问题和手术相关症状等多维度。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire-Lung Cancer 13 (QLQ-LC13) assesses quality of life (QOL) in patients with lung cancer and was the first EORTC module developed for use in international clinical trials. Since its publication in 1994, major treatment advances with possible effects on QOL have occurred. These changes called for an update of the module and its international psychometric validation. We aimed to investigate the scale structure and psychometric properties of the updated lung cancer module, QLQ-LC29, in patients with lung cancer. METHODS: This international, observational field study was done in 19 hospitals across 12 countries. Patients aged older than 18 years with a confirmed diagnosis of lung cancer and no other previous primary tumour, and who were mentally fit with sufficient language skills to understand and complete the questionnaire were included. Patients were asked during a hospital visit to fill in the paper versions of the core questionnaire EORTC QLQ-C30 plus QLQ-LC29, and investigators selected half of these patients to complete the questionnaire again 2-4 weeks later. Our primary aim was to assess the scale structure and psychometric properties of EORTC QLQ-LC29. We analysed scale structure using confirmatory factor analysis; reliability using Cronbach's α value (internal consistency) and intra-class coefficient (test-retest reliability); sensitivity using independent t tests stratified by Karnofsky performance status; and responsiveness to change over time by ANOVA. This study is registered with ClinicalTrials.gov, NCT02745691. FINDINGS: Between April 12, 2016, and Sept 26, 2018, 523 patients with a confirmed diagnosis of either non-small-cell lung cancer (n=442) or small-cell lung cancer (n=81) were recruited. Confirmatory factor analysis provided a solution composed of five multi-item scales (coughing, shortness of breath, fear of progression, hair problems, and surgery-related symptoms) plus 15 single symptom or side-effect items: χ2=370·233, root mean square error of approximation=0·075, and comparative-fit index=0·901. Cronbach's α for internal consistencies of all multi-item scales were above the threshold of 0·70. Intra-class coefficients for test-retest reliabilities ranged between 0·82 and 0·97. Three (shortness of breath, fear of progression, and hair problems) of the five multi-item scales showed responsiveness to change over time (p values <0·05), as did nine of 15 single symptom items. Four (coughing, shortness of breath, fear of progression, and surgery-related symptoms) of the five multi-item scales and ten of the 15 single symptom items were sensitive to known group differences (ie, lower vs higher Karnofsky performance status). INTERPRETATION: Results determined the psychometric properties of the updated lung cancer module, which is ready for use in international clinical studies. FUNDING: EORTC Quality of Life Group.

来源:Lancet Oncol,查看原文。版权归原作者所有。

引用

  1. Koller M, Shamieh O, Hjermstad MJ, et al. Psychometric properties of the updated EORTC module for assessing quality of life in patients with lung cancer (QLQ-LC29): an international, observational field study. Lancet Oncol. 2020. PMID: 32213338. doi:10.1016/S1470-2045(20)30093-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。